Under Pressure: The Pharmacist’s Role in Pulmonary Arterial Hypertension
ACPE Activity Number: 0204-0000-26-404-H01-P Content Release Date: February 24, 2026 Expiration Date: February 24, 2027 Activity Type: Knowledge-based CE Credits: 0.5 contact hours (0.05 CEUs) Activity Fee: Free
Activity Overview
The last 30 years have seen significant advances in the diagnosis, treatment, and management of pulmonary arterial hypertension (PAH). Improvements in understanding the pathways underlying endothelial dysfunction and vascular arteriole remodeling involved in the pathogenesis of PAH, targeted therapies, and enhanced diagnostic and monitoring tools are reflected in new evidence-based guidelines.
This CE podcast will address the pathogenesis of PAH and the challenges of treating patients with PAH including the burden on the patient, the pharmacist’s role in PAH care, treatment specific considerations, and transitions of care.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
This activity was planned to meet the educational needs of pharmacists who practice in hospitals, health systems, ambulatory clinics, and community settings who care for or are interested in the care of patients with pulmonary arterial hypertension.
After participating in this CPE activity, learners should be able to:
Describe the key pathways involved in the pathogenesis of PAH and the challenges of treating patients with PAH including the burden on the patient, considerations for transitions of care, and opportunities to optimize therapy.
Jared Frost, PharmD, BCCP, Activity Chair Clinical Pharmacy Specialist – Cardiology Cardiology Pharmacy Residency Director Advocate Health – Aurora St. Luke's Medical Center Milwaukee, Wisconsin
Jared Frost, PharmD, BCCP is a Clinical Pharmacy Specialist in cardiology and the PGY2 Cardiology Residency Program Director at Aurora St. Luke's Medical Center in Milwaukee, WI. Dr. Frost earned his Doctor of Pharmacy degree from Drake University and completed both PGY1 and PGY2 Cardiology Pharmacy Residencies at Aurora St. Luke's. In his current role he oversees medication practices across the cardiac catheterization and electrophysiology labs, cardiovascular surgery, and pulmonary hypertension services. Dr. Frost is an active member of the American College of Cardiology, the National Lipid Association, and the Pharmacy Society of Wisconsin.
Zachary Klick, PharmD, BCCP, BCPS, BCACP, CPP Cardiology Pharmacist Cardiology Pharmacy Residency Program Director Atrium Health Wake Forest Baptist Winston Salem, North Carolina
Zachary Klick, PharmD, BCPS, BCACP, BCCP, CPP, is a board-certified clinical pharmacist specializing in cardiology. He earned his PharmD from Duquesne University and completed his PGY1 at Carilion Clinic Roanoke Memorial Hospital, followed by a PGY2 in Cardiology at HCA/UTHSC. Dr. Klick has experience in both inpatient and outpatient cardiology, managing patients with advanced heart failure, pulmonary hypertension, and coronary artery disease. He is one of the editors of the recently published textbook Raj’s Practical Management of Pain, Sixth Edition, and co-author of Defeat Chronic Pain Now, a book written for people with chronic pain. He has recently published the fourth edition of Pain Management Secrets. He is on the editorial board for the Clinical Journal of Pain.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
No one in control of the content of this activity has a relevant financial relationship (RFR) with an ineligible company.
As defined by the Standards of Integrity and Independence in Accredited Continuing Education definition of ineligible company.
Per ACPE requirements, CPE credit must be claimed within 60 days of being earned – no exceptions! To verify that you have completed the required steps and to ensure your credits have been reported to CPE Monitor, we encourage you to check your NABP eProfile account to validate your credits were transferred successfully before the ACPE 60-day deadline. After the 60 day deadline, ASHP will no longer be able to award credit for this activity.
